ARIC - JHU FIELD CENTER - DIVERSITY SUPPLEMENT

ARIC - JHU 野外中心 - 多样性补充

基本信息

  • 批准号:
    10054600
  • 负责人:
  • 金额:
    $ 23.38万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-09-16 至 2020-08-31
  • 项目状态:
    已结题

项目摘要

The Atherosclerosis Risk in Communities (ARIC) Study was initiated in 1985 with two components: community-based surveillance and a prospective cohort study. The community surveillance aimed to monitor trends in hospitalized myocardial infarction (MI), fatal coronary heart disease (CHD) in four U.S. communities: Forsyth County, NC; Jackson, MS; suburbs of Minneapolis, MN; and Washington County, MD. Surveillance for hospitalized heart failure (HF) events was added in 2005. The communities were selected to provide data across four (4) geographic locations with a range of mortality rates, in urban, suburban, and rural settings. The cohort study aimed to investigate the risk factors for and natural history of atherosclerosis and development of clinical atherosclerosis in middle-aged white or African American adults from the same communities. The study recruited in 15,792 white or African American participants initially aged 45-64 years and selected participants received triennial clinical exams over the first ten years of the study (1987-1989, 1990-1992, 1993-1995, and 1996-1998), with a fifth clinical exam in 2011-2013, providing a rich set of data on physical, behavioral, genetic, and psychosocial factors. Since 1988, the cohort has been contacted annually and in 2011 semiannual follow-up was initiated. Findings have been presented in over 1,400 publications as of 2014. Participants were examined for evidence of subclinical atherosclerosis using B-mode ultrasound in carotid and popliteal arteries, ankle-brachial index measurement, and retinal photography and, in subsets, abdominal aortic CT, and hemostatic factors; established and putative laboratory risk markers; socioeconomic, psychological, behavioral, and environmental characteristics; and genetic factors. Examinations included a variety of components, with a grant-funded detailed cognitive function testing component added in the most recent exam during 2011-2013. Blood samples have been assayed for putative biochemical risk factors and stored for case-control studies. DNA has been extracted and lymphocytes cryopreserved (for possible immortalization) for study of candidate genes, genome-wide scanning, expression, and other –omics investigations. Participation of the surviving cohort was 91, 82, 74, and 65% at each of the respective follow-up examinations. Since baseline, cohort members have also been contacted every 12 months to obtain information on vital status, current residence, major illness or injury, and hospitalizations occurring between contacts to identify clinical Cardiovascular Disease (CVD) events. Cohort contact was 84% at the last completed follow-up ending on December 31, 2013.
社区动脉粥样硬化风险 (ARIC) 研究始于 1985 年,包括两个部分:基于社区的监测和前瞻性队列研究。社区监测旨在监测住院心肌梗塞 (MI) 和致命性冠心病 (CHD) 的趋势。新增了四个美国社区:北卡罗来纳州福赛斯县、密西西比州杰克逊市、明尼苏达州明尼阿波利斯市郊区和马里兰州华盛顿县。 2005 年。选择社区提供四 (4) 个地理位置的城市、郊区和农村地区不同死亡率的数据。该队列研究旨在调查动脉粥样硬化及其发展的风险因素和自然史。该研究招募了 15,792 名年龄在 45 岁至 64 岁之间的白人或非裔美国人参与者,并在前十年内每三年接受一次临床检查。该研究(1987-1989年、1990-1992年、1993-1995年和1996-1998年)进行了第五次临床检查,并于2011-2013年进行了第五次临床检查,提供了自1988年以来有关身体、行为、遗传和心理社会因素的丰富数据。 ,每年都会联系该队列,并于 2011 年启动半年一次的随访调查结果。截至 2014 年,已发表超过 1,400 篇出版物。使用颈动脉和腘动脉 B 型超声、踝肱指数测量和视网膜摄影,以及腹主动脉 CT 和确定的止血因素,对参与者进行了亚临床动脉粥样硬化的证据检查;假定的实验室风险标记;社会经济、心理、行为和环境特征;检查包括各种组成部分,以及资助的详细认知功能。 2011-2013 年最近一次检查中添加了测试成分,已对血液样本进行了假定的生化危险因素分析,并提取了 DNA 以用于病例对照研究,并冷冻保存了淋巴细胞(用于可能的永生化)以用于研究候选基因、基因组。自基线以来,存活队列的参与率分别为 91%、82%、74% 和 65%。每 12 个月就会联系一次队列成员,以获取有关生命状况、当前居住地、重大疾病或受伤以及接触期间发生的住院情况的信息,以识别临床心血管疾病 (CVD) 事件。在上次完成时,队列接触率为 84%。后续行动于 2013 年 12 月 31 日结束。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JOSEF CORESH其他文献

JOSEF CORESH的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JOSEF CORESH', 18)}}的其他基金

Resource Development Core
资源开发核心
  • 批准号:
    10747706
  • 财政年份:
    2023
  • 资助金额:
    $ 23.38万
  • 项目类别:
Long-term effects of hearing intervention on brain health in the Aging and Cognitive Health Evaluation in Elders (ACHIEVE) randomized study
老年人衰老和认知健康评估 (ACHIEVE) 随机研究中听力干预对大脑健康的长期影响
  • 批准号:
    10680434
  • 财政年份:
    2022
  • 资助金额:
    $ 23.38万
  • 项目类别:
Long-term effects of hearing intervention on brain health in the Aging and Cognitive Health Evaluation in Elders (ACHIEVE) randomized study
老年人衰老和认知健康评估 (ACHIEVE) 随机研究中听力干预对大脑健康的长期影响
  • 批准号:
    10418325
  • 财政年份:
    2022
  • 资助金额:
    $ 23.38万
  • 项目类别:
THE ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) STUDY - FIELD CENTER - TASK ORDER 01, TASK AREA A
社区动脉粥样硬化风险 (ARIC) 研究 - 现场中心 - 任务令 01,任务区 A
  • 批准号:
    10620984
  • 财政年份:
    2021
  • 资助金额:
    $ 23.38万
  • 项目类别:
THE ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) STUDY - FIELD CENTER - TASK ORDER 01, TASK AREA A
社区动脉粥样硬化风险 (ARIC) 研究 - 现场中心 - 任务令 01,任务区 A
  • 批准号:
    10788250
  • 财政年份:
    2021
  • 资助金额:
    $ 23.38万
  • 项目类别:
Integrative Omics, Chronic Kidney Disease, and Adverse Outcomes in Older Adults
综合组学、慢性肾病和老年人的不良后果
  • 批准号:
    10368118
  • 财政年份:
    2020
  • 资助金额:
    $ 23.38万
  • 项目类别:
Integrative Omics, Chronic Kidney Disease, and Adverse Outcomes in Older Adults
综合组学、慢性肾病和老年人的不良后果
  • 批准号:
    10163839
  • 财政年份:
    2020
  • 资助金额:
    $ 23.38万
  • 项目类别:
Aging, Cognition, and Hearing Evaluation in Elders (ACHIEVE) Randomized Trial
老年人的衰老、认知和听力评估 (ACHIEVE) 随机试验
  • 批准号:
    9287053
  • 财政年份:
    2017
  • 资助金额:
    $ 23.38万
  • 项目类别:
Aging, Cognition, and Hearing Evaluation in Elders (ACHIEVE) Randomized Trial
老年人的衰老、认知和听力评估 (ACHIEVE) 随机试验
  • 批准号:
    9986336
  • 财政年份:
    2017
  • 资助金额:
    $ 23.38万
  • 项目类别:
IGF::OT::IGF ATHEROSCLEROSIS IN RISK COMMUNITIES - FIELD CENTER - CORE STUDY OPERATIONS
IGF::OT::IGF 动脉粥样硬化风险社区 - 现场中心 - 核心研究操作
  • 批准号:
    10329837
  • 财政年份:
    2016
  • 资助金额:
    $ 23.38万
  • 项目类别:

相似国自然基金

通过WISE巡天和MPA-JHU源表估算星系的恒星质量
  • 批准号:
    11563005
  • 批准年份:
    2015
  • 资助金额:
    47.0 万元
  • 项目类别:
    地区科学基金项目

相似海外基金

MU-JHU Research Collaboration - Increased Community Participation in Research pla
MU-JHU 研究合作 - 增加社区对研究计划的参与
  • 批准号:
    7642919
  • 财政年份:
    2009
  • 资助金额:
    $ 23.38万
  • 项目类别:
MU-JHU Research Collaboration - Increased Community Participation in Research pla
MU-JHU 研究合作 - 增加社区对研究计划的参与
  • 批准号:
    8118149
  • 财政年份:
    2009
  • 资助金额:
    $ 23.38万
  • 项目类别:
MU-JHU Research Collaboration - Increased Community Participation in Research pla
MU-JHU 研究合作 - 增加社区对研究计划的参与
  • 批准号:
    7891278
  • 财政年份:
    2009
  • 资助金额:
    $ 23.38万
  • 项目类别:
JHU Center for the Advancement of HIV Neurotherapeutics (JHU CAHN) - Biomarker Core
JHU Center for the Advancement of HIV Neurotherapy (JHU CAHN) - 生物标志物核心
  • 批准号:
    10584555
  • 财政年份:
    2006
  • 资助金额:
    $ 23.38万
  • 项目类别:
JHU Center for the Advancement of HIV Neurotherapeutics (JHU CAHN) - Biomarker Core
JHU Center for the Advancement of HIV Neurotherapy (JHU CAHN) - 生物标志物核心
  • 批准号:
    10475439
  • 财政年份:
    2006
  • 资助金额:
    $ 23.38万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了